DESERT MOUNTAIN ENERGY CORP (DME.CA) Fundamental Analysis & Valuation

TSX-V:DME • CA25043D1078

Current stock price

0.375 CAD
-0.08 (-17.58%)
Last:

This DME.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DME.CA Profitability Analysis

1.1 Basic Checks

  • In the past year DME has reported negative net income.
  • DME had a negative operating cash flow in the past year.
  • DME had negative earnings in each of the past 5 years.
  • DME had a negative operating cash flow in each of the past 5 years.
DME.CA Yearly Net Income VS EBIT VS OCF VS FCFDME.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

  • The Return On Assets of DME (-9.15%) is better than 62.77% of its industry peers.
  • DME has a better Return On Equity (-9.80%) than 65.94% of its industry peers.
Industry RankSector Rank
ROA -9.15%
ROE -9.8%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DME.CA Yearly ROA, ROE, ROICDME.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for DME so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DME.CA Yearly Profit, Operating, Gross MarginsDME.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. DME.CA Health Analysis

2.1 Basic Checks

  • DME does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for DME. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DME.CA Yearly Shares OutstandingDME.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M
DME.CA Yearly Total Debt VS Total AssetsDME.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M

2.2 Solvency

  • An Altman-Z score of 6.45 indicates that DME is not in any danger for bankruptcy at the moment.
  • DME has a Altman-Z score of 6.45. This is comparable to the rest of the industry: DME outperforms 57.42% of its industry peers.
  • DME has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.45
ROIC/WACCN/A
WACC10.91%
DME.CA Yearly LT Debt VS Equity VS FCFDME.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 2.00 indicates that DME should not have too much problems paying its short term obligations.
  • DME's Current ratio of 2.00 is in line compared to the rest of the industry. DME outperforms 51.22% of its industry peers.
  • A Quick Ratio of 2.00 indicates that DME should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 2.00, DME is in line with its industry, outperforming 53.77% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 2
DME.CA Yearly Current Assets VS Current LiabilitesDME.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. DME.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 63.08% over the past year.
  • DME shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -50.66%.
EPS 1Y (TTM)63.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-50.66%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-57.12%

3.2 Future

  • Based on estimates for the next years, DME will show a very strong growth in Earnings Per Share. The EPS will grow by 73.21% on average per year.
  • Based on estimates for the next years, DME will show a very strong growth in Revenue. The Revenue will grow by 256.37% on average per year.
EPS Next Y60%
EPS Next 2Y73.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year310%
Revenue Next 2Y256.37%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

DME.CA Yearly Revenue VS EstimatesDME.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
DME.CA Yearly EPS VS EstimatesDME.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0 0.02 -0.02 0.04 -0.04 -0.06

More info and screens

Find the best growth stocksShow best growing peers

4

4. DME.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DME. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 7.28, which indicates a rather cheap valuation of DME.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of DME indicates a rather cheap valuation: DME is cheaper than 93.55% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.04, DME is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 7.28
DME.CA Price Earnings VS Forward Price EarningsDME.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DME.CA Per share dataDME.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

  • DME's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as DME's earnings are expected to grow with 73.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y73.21%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DME.CA Dividend Analysis

5.1 Amount

  • No dividends for DME!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DME.CA Fundamentals: All Metrics, Ratios and Statistics

DESERT MOUNTAIN ENERGY CORP

TSX-V:DME (3/16/2026, 7:00:00 PM)

0.375

-0.08 (-17.58%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-26
Earnings (Next)05-27
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.63%
Ins Owner ChangeN/A
Market Cap36.01M
Revenue(TTM)860.30K
Net Income(TTM)-4.58M
Analysts84.44
Price Target0.51 (36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-85.34%
Min Revenue beat(2)-94.84%
Max Revenue beat(2)-75.84%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.28
P/S 41.86
P/FCF N/A
P/OCF N/A
P/B 0.77
P/tB 0.77
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)0.05
Fwd EY13.73%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.01
BVpS0.49
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.15%
ROE -9.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr -27696.2%
Cap/Sales 170.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2
Quick Ratio 2
Altman-Z 6.45
F-Score3
WACC10.91%
ROIC/WACCN/A
Cap/Depr(3y)5568.56%
Cap/Depr(5y)38613%
Cap/Sales(3y)1760.59%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y60%
EPS Next 2Y73.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-50.66%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-57.12%
Revenue Next Year310%
Revenue Next 2Y256.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y23.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year84.3%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y79.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.32%
OCF growth 3YN/A
OCF growth 5YN/A

DESERT MOUNTAIN ENERGY CORP / DME.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DESERT MOUNTAIN ENERGY CORP?

ChartMill assigns a fundamental rating of 3 / 10 to DME.CA.


What is the valuation status for DME stock?

ChartMill assigns a valuation rating of 4 / 10 to DESERT MOUNTAIN ENERGY CORP (DME.CA). This can be considered as Fairly Valued.


What is the profitability of DME stock?

DESERT MOUNTAIN ENERGY CORP (DME.CA) has a profitability rating of 1 / 10.


Can you provide the financial health for DME stock?

The financial health rating of DESERT MOUNTAIN ENERGY CORP (DME.CA) is 6 / 10.


What is the earnings growth outlook for DESERT MOUNTAIN ENERGY CORP?

The Earnings per Share (EPS) of DESERT MOUNTAIN ENERGY CORP (DME.CA) is expected to grow by 60% in the next year.